СУЧАСНІ МЕТОДИ ВИЗНАЧЕННЯ ДІУРЕТИКІВ У ФАРМАЦЕВТИЧНИХ ТА БІОЛОГІЧНИХ ОБ'ЄКТАХ
УДК 543.645.9+543.062
Ключові слова:
хроматографічні методи, спектроскопічні методи, діуретикиАнотація
Проведено аналіз даних літератури щодо сучасних методів визначення і виявлення діуретиків у фармацевтичних препаратах та біологічних рідинах. Показано, що до найбільш розповсюджених відносяться хроматографічні та спектроскопічні, зокрема люмінесцентні, методи. Складність біологічних матриць та низький вміст діуретиків передбачає проведення стадії попереднього концентрування аналітів та їх відокремлення від компонентів матриці.
Посилання
1. Brater D. Pharmacology of diuretics / D. Brater, M.D. Craig //
Am. J. Med. Sci. – 2000. – Vol. 319, № 1. – P. 38–47.
2. Ventura R. Detection of diuretic agents in doping control / R. Ventura, J. Segura // J. Chromatogr. B. – 1996. - Vol. 687, № 1. – P. 127–144.
3. Delbeke F. T. The influence of diuretics on the excretion and metabolism of doping agents. Part IV – Caffeine / F. T. Delbeke, M. Debackere // Biopharm. Drug Dispos. – 1988. – Vol. 9, № 2. – P. 137–145.
4. Delbeke F.T. The influence of diuretics on the excretion and metabolism of doping agents. Part I – Mephentermine / F.T. Delbeke, M. Debackere // J. Pharm. Biomed. Anal. – 1985. – Vol. 3, № 2. – P. 141–148.
5. Delbeke F.T. The influence of diuretics on the excretion and metabolism of doping agents. Part V – Dimefline / F.T. Delbeke, M. Debackere // J. Pharm. Biomed. Anal. – 1991. – Vol. 9, № 1. – P. 23–28.
6. Effects of formulation and food on the absorption of hydrochlorothiazide and triamterene or amiloride from combination diuretic products / R.L. Williams, J. Mordenti, R. Upton et al. // Pharm. Res. – Vol. 4, № 4. – 1987. – P. 348–352.
7. The world anti-doping code–the 2009 prohibited list: international standard. – Montreal: World Anti-Doping Agency, 2009. – 9 p.
8. Minimum required performance limits for detection of prohibited substances: technical document TD2010MRPL. – Montreal: World Anti-Doping Agency, 2010. – 1 p.
9. Morganti A. Should a diuretic always be the first choice in patients with essential hypertension? The case for no / A. Morganti // J. Am. Society Nephrol. – 2005. – Vol. 16. – P. 70–73.
10. Ventura R. Fast screening method for diuretics, probenecid and other compounds of doping interest / R. Ventura, T. Nadal, P. Alcalde, et. all. // J. Chromatogr. A. – 1993. – Vol. 655, № 2. – P. 233–242.
11. O'Brien J.G. Treatment of Edema / J.G. O'Brien, S.A. Chennubhotla, R.V. Chennubhotla // Am. Fam. Physician. – 2005. – Vol. 71, № 11. – P. 2111–2117.
12. Dikshit K. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction / K. Dikshit, J.K. Vyden, J.S. Forrester et al. // N. Engl. J. Med. – 1973. – Vol. 288, № 21. – P. 1087–1090.
13. Pharmacokinetics of furosemide in patients with hepatic cirrhosis / G. Gonzalez, A. Arancibia, M.I. Rivas et al. // Eur. J. Clin. Pharmacol. – 1982. – Vol. 22, № 4. – P. 315–320.
14. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC 7) / A.V. Chobanian, G.L. Bakris, H.R. Black et al. // Hypertension. – 2003. – Vol. 42, № 6. – P. 1206–1252.
15. Jackson E.K. Diuretics / L.L. Brunton, J.S. Lazo, K.L. Parker. Goodman & Gilman's the pharmacological basis of therapeutics. – New York: McGraw-Hill, 2006. – 1808 p.
16. Hughes A.D. How do thiazide and thiazide-like diuretics lower blood pressure? / A.D. Hughes // J. Renin Angiotensin Aldosterone Syst. – 2004. – Vol. 5, № 4. – P. 155–160.
17. Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase / Z. Zhu, S. Zhu, D. Liu et al. // Hypertension. – 2005. – Vol. 45, № 2. – P. 233–239.
18. Lippincott's Illustrated Reviews: Pharmacology / [Finkel R., Clark M. A., Cubeddu L. X.]. – Philadelphia: Lippincott Williams & Wilkins, 2009. – 564 p.
19. Kulichenko S.A. Titrimetric determination of furosemide using aqueous–micellar solutions of surfactants / S.A. Kulichenko, S.A. Fesenko // J. Anal. Chem. – 2002. – Vol. 57, № 3. – P. 231–234.
20. Ferraro M.C.F. A spectrophotometric-partial least squares (PLS-1) method for the simultaneous determination of furosemide and amiloride hydrochloride in pharmaceutical formulations / M.C.F. Ferraro, P.M. Castellano, T.S. Kaufman // J. Pharm. Biomed. Anal. – 2001. – Vol. 26, № 3. – P. 443–451.
21. Spectrophotometric determination of furosemide and its palladium(II) complex / S. Agotonovic-Kustrin, Lj. Zivanovic, D. Radulovic et al. // J. Pharm. Biomed. Anal. – 1990. – Vol. 8, № 8–12. – P. 983–986.
22. Flow-injection spectrophotometric determination of frusemide or sulpha¬thiazole in pharmaceuticals / M.S. Garcia, C. Sanchez-Pedreno, M.I. Albero et al. // J. Pharm. Biomed. Anal. – 1997. – Vol. 15, № 4. – P. 453–459.
23. Zivanovic L. Spectrophotometric determination of furosemide as its Fe(III) complex in pharmaceutical preparations / L. Zivanovic, S. Agatonovic, D. Radulovic // Mikrochim. Acta. – 1990. – Vol. 100, № 1-2. – P. 49–54.
24. Spectrofluorimetric determination of anthranilic acid derivatives based on terbium sensitized fluorescence / P.C. Ioannou, N.V. Rusakova, D.A. Andrikopoulou et al. // Analyst. – 1998. – Vol. 123, № 12. – P. 2839–2843.
25. A fluorimetric method for the estimation of bumetanide / R.B. Patel, A.A. Patel, M.R. Patel et al. // Ind. J. Pharm. Sci. – 1987. – Vol. 49, № 4. – P. 142–143.
26. Micellar electrokinetic capillary chromatography analysis of diuretics in pharmaceutical formulations / M.L. Luis, S. Corujedo, D. Blanco et al. // Talanta. – 2002. – Vol. 57, № 2. – P. 223–231.
27. Use of capillary electrophoresis for testing the stability of a drug mixture in perfusional solution / M.G. Quaglia, E. Bossu, C. Desiderio et al. // Farmaco. – 1994. – Vol. 49, № 6. – P. 403–406.
28. González E. Direct determination of diuretic drugs in urine by capillary zone electrophoresis using fluorescence detection / E. González, A. Becerra, J.J. Laserna // J. Chromatogr. B. – 1996. – Vol. 687, № 1. – P. 145–150.
29. Riekkola M.L. Capillary electrophoresis of diuretics / M.L. Riekkola, J.H. Jumppanen // J. Chromatogr. A. – 1996. – Vol. 735, № 1–2. – P. 151–164.
30. Ferraro M.C.F. Chemometric determination of amiloride hydrochloride, atenolol, hydrochlorothiazide and timolol maleate in synthetic mixtures and pharmaceutical formulations / M.C.F Ferraro, P.M. Castellano, T.S. Kaufman // J. Pharm. Biomed. Anal. – 2004. – Vol. 34, № 2. – P. 305–314.
31. Continuous-flow chemiluminometric determination of amiloride and streptomycin by oxidation with N-bromosuccinimide / S.A. Halvatzis, A.M. Mihalatos, L.P. Palilis et al. // Anal. Chim. Acta. – 1994. – Vol. 290, № 1–2. – P. 172–178.
32. FI-chemiluminometric study of thiazides by on-line photochemical reaction / M. Ciborowski, M.C. Icardo, J.V. Garcia Mateo et al. // J. Pharm. Biomed. Anal. – 2004. – Vol. 36, № 4. – P. 693–700.
33. Investigation of RuBPS–Ce(IV) chemiluminescence reaction and its application in determination of two diuretics / J. Xia, X. Jia, Sh. Zhang et al. // Anal. Chim. Acta. – 2005. – Vol. 541, № 1-2. – P. 193–198.
34. Cerium (IV)-based chemiluminescence analysis of hydrochlorothiazide / J. Ouyang, W.R.G. Baeyens, J. Delanghe et al. // Talanta. – 1998. – Vol. 46, № 5. – P. 961–968.
35. Pulgarin J.A.M. Determination of hydrochlorothiazide in pharmaceutical preparations by time resolved chemiluminescence / J.A.M. Pulgarin, A.A. Molina, G.P. Nieto // Anal. Chim. Acta. – 2004. – Vol. 518, № 1-2. – P. 37–43.
36. Pulgarín J.A.M. Rapid determination of hydroflumethiazide in dosage forms by time-resolved chemiluminescence / J.A.M. Pulgarín, A.A. Molina, G.P. Nieto // Microchim. Acta. – 2007. – Vol. 159, № 3-4. - P. 349-356.
37. Direct determination of triamterene by potentiometry using a coated wire selective electrode / M. Arvand, M.F. Mousavi, M.A. Zanjanchi et al. // J. Pharm. Biomed. Anal. – 2003. – Vol. 33, № 5. – P. 975–982.
38. Determination of triamterene and its main metabolite hydroxytriamterene sulfate in human urine by capillary electrophoresis using ultraviolet absorbance and laser-induced fluorescence detection / C. Horstkötter, S. Kober, H. Spahn-Langguth et al. // J. Chromatogr. B. – 2002. – Vol. 769, № 1. – P. 107–117.
39. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high- performance liquid chromatography-tandem mass spectrometry. Comparison between liquid-liquid extraction and direct injection / K. Deventer, O.J. Pozo, P. Van Eenoo et al. // J. Chromatogr. A. – 2009. – Vol. 1216, № 31. – P. 5819–5827.
40. Mazzarino M. A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-estrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS / M. Mazzarino, X. de la Torre, F. Botrè // Anal. Bioanal. Chem. – 2008. – Vol. 392, № 4. – P. 681–698.
41. Development and validation of a qualitative screening method for the detection of exogenous anabolic steroids in urine by liquid chromatography-tandem mass spectrometry / O.J. Pozo, P. Van Eenoo, K. Deventer et al. // Anal. Bioanal. Chem. – 2007. – Vol. 389, № 4. – P. 1209–1224.
42. Fullinfaw R. Liquid chromatographic screening of diuretics in urine / R. Fullinfaw, R. Bury, R. Moulds // J. Chromatogr. A. – 1987. – Vol. 415. – P. 347–356.
43. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents / R. Ventura, M. Roig, N. Monfort et al. // Eur. J. Mass Spectrom. – 2008. – Vol. 14, № 3. – P. 191–200.
44. Лебедев А.Т. Масс-спектрометрия в органической химии / Лебе-дев А.Т. – М.: Бином. Лаборатория знаний, 2003. – 493 с.
45. Morra V. Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine. Development and validation of a productive screening protocol for anti-doping analysis / V. Morra, P. Davit, P. Capra // J. Chromatogr. A. – 2006. – Vol. 1135, № 2. – P. 219–229.
46. Rapid determination of diuretics in human urine by gas chromatography-mass spectrometry following microwave assisted derivatization / L. Amendola, C. Colamonici, M. Mazzarino et al. // Anal. Chim. Acta. – 2003. – Vol. 475, № 1–2. – P. 125–136.
47. High-speed gas chromatography in doping control: fast-GC and fast-GC/MS determination of β-adrenoceptor ligands and diuretics / C. Brunelli, C. Bicchi, A. Di Stilo et al. // J. Sep. Sci. – 2006. – Vol. 29, № 18. – P. 2765–2771.
48. Detection of diuretics in urine during sports events in Taiwan / Y.L. Tseng, M.H. Shieh, C.T. Lin et al. // Tzu Chi Med. J. – 2004. – Vol. 16, № 2. – P. 69–77.
49. Van Eenoo P. Criteria in chromatography and mass-spectrometry–a comparison between regulations in the field of residue and doping analysis / P. Van Eenoo, F.T. Delbeke // Chromatographia. – 2004. – Vol. 59, № 1. – P. 39–44.
50. Politi L. A direct screening procedure for diuretics in human urine by liquid chromatography-tandem mass spectrometry with information dependent acquisition / L. Politi, L. Morini, A. Polettini // Clin. Chim. Acta. – 2007. – Vol. 386, № 1–2. – P. 46–52.
51. Goebel C. Rapid screening method for diuretics in doping control using automated solid phase extraction and liqud chromatography-electrospray tandem mass spectrometry / C. Goebel, G. Trout, R. Kazlauskas // Anal. Chim. Acta. – 2004. – Vol. 502, № 1. – P. 65–74.
52. Screening, confirmation and quantification of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionization tandem mass spectrometry / D. Thieme, J. Grosse, R. Lang et al. // J. Chromatogr. B. – 2001. – Vol. 757, № 1. – P. 49–57.
53. Zaporozhets O. Determination of 8 diuretics and probenecid in human urine by gas-chromatography – mass spectrometry: confirmation procedure / O.Zaporozhets, I. Tsyrulneva, M. Ischenko // Am. J. Anal. Chem. – 2012. – Vol. 3. – P. 320–327
54. Systematic analysis of diuretic doping agents by HPLC screening and GC/MS confirmation / S.J. Park, H.S. Pyo, Y.J. Kim et al. // J. Anal. Toxicol. – 1990. – Vol. 14, No. 2. – P. 84–90.
55. Spectrophotometric methods for the determination of some diuretics using 3-methyl-2-benzothiazolinone hydrazone / C.S.P. Sastry, T.N.V. Prasad, B.S. Sastry et al. // Analyst. – 1988. – Vol. 113, № 2. – P. 255–258.
56. Kartal M. Simultaneous determination of hydrochlorothiazide and amiloride hydrochloride by ratio spectra derivative spectrophotometry and high-performance liquid chromatography / M. Kartal, N. Erk // J. Pharm. Biomed. Anal. – 1999. – Vol. 19, № 3–4. – P. 477–485.
57. Ferraro M.C. Simultaneous determination of amiloride hydrochloride and hydrochlorothiazide in synthetic samples and pharmaceutical formulations by multivariate analysis of spectrophotometric data / M.C. Ferraro, P.M. Castellano, T. S. Kaufman // J. Pharm. Biomed. Anal. – 2002. – Vol. 30, № 4. – P. 1121–1131.
58. Omar M.A. Spectrophotometric and spectrofluorimetric determination of certain diuretics through ternary complex formation with eosin and Lead (II) / M.A. Omar // J. Fluoresc. – 2010. – Vol. 20, № 1. – P. 275–281.
59. Pulgarin J.A.M. Direct analysis of amiloride and triamterene mixtures by fluorescence spectrometry using partial-least squares calibration / J.A.M Pulgarin, A.A. Molina, P.F. Lopez // Anal. Chim. Acta. – 2001. – Vol. 449, № 1–2. – P. 179–187.
60. Pulgarin J.A.M. Simultaneous direct determination of amiloride and triamterene in urine using isopotential fluorometry / J.A.M. Pulgarin, A.A Molina, P.F. Lopez // Anal. Biochem. – 2001. – Vol. 292, № 1. – P. 59–68.
61. Tsyrulneva I. Simple and Rapid Determination of Diuretics by Luminescent Method / I. Tsyrulneva, O. Zaporozhets // Pharm. Pharm. – 2013. – Vol. 4. – P. 520–527.
62. Hurtubise R.J. Solid-matrix luminescence analysis: photophysics, physicochemical interactions and applications / R.J. Hurtubise // Anal. Chim. Acta. – 1997. – Vol. 351, № 1–3. – P. 1–22.
63. Solid-surface room temperature phosphorescence / M. Gunshefski, J.J. Santana, J. Stephenson et. al. // Appl. Spectrosc. – 1992. – Vol. 27, № 2. – P. 143–192.
64. Escandar G.M. Phosphorescence properties of p-aminobenzoic acid immobilized on a nylon membrane / G.M. Escandar // Appl. Spectrosc. – 2004. – Vol. 58, № 7. – P. 836–842.
65. Determination of carbamazepine in serum and pharmaceutical preparations using immobilization on a nylon support and fluorescence detection / G.M. Escandar, D.G. Gomez, A.E. Mansilla et al. // Anal. Chim. Acta. – 2004. – Vol. 506, № 2. – P. 161–170.
66. Hagestuen E.D. On the improvement of solid-phase extraction room-temperature phosphorimetry for the analysis of polycyclic aromatic hydrocarbons in water samples / E.D. Hagestuen, A.F. Arruda, A.D. Campiglia // Talanta. – 2000. – Vol. 52, № 4. – P. 727–737.
67. Determination of triamterene in pharmaceutical formulations and of triamterene and its main metabolite hydroxytriamterene sulfate in urine using solid-phase and aqueous solution luminescence / G.A. Ibanez, G.M. Escandar, A.E. Mansilla et al. // Anal. Chim. Acta. – 2005. – Vol. 538, № 2. – P. 77–84.
68. Peralta C.M. Solid phase extraction using nylon membranes with fluorescence detection as a fast and sensitive method for Amiloride and Furosemide determination in urine samples / C.M. Peralta, L.P. Fernández, A.N. Masi // Microchem. J. – 2011. – Vol. 98, № 1. – P. 39–43.
69. Molecularly imprinted solid phase extraction for the selective HPLC determination of α-tocopherol in bay leaves / F. Puoci, G. Cirillo, M. Curcio et al. // Anal. Chim. Acta. – 2007. – Vol. 593, № 2. – P. 164–170.
70. Baggiani C. Solid phase extraction of food contaminants using molecular imprinted polymers / C. Baggiani, L. Anfossi, C. Giovannoli // Anal. Chim. Acta. – 2007. – Vol. 591, № 1. – P. 29–39.
71. Molecularly imprinted polymers for the recognition of proteins: The state of the art / A. Bossi, F. Bonini, A.P.F. Turner et al. // Biosens. Bioelectron. – 2007. – Vol. 22, № 6. – P. 1131–1137.
72. Molecularly imprinted submicronspheres for applications in a novel model biosensor-film / I. Morelli, V. Chiono, G. Vozzi et al. // Sens. Actuators B. – 2010. – Vol. 150, № 1. – P. 394–401.
73. A synthetic nanomaterial for virus recognition produced by surface imprinting / A. Cumbo, B. Lorber, P. F. Corvini et al. // Nat. Commun. – 2013. – Vol. 4. – P. 1503.
74. Andersson L.I. Molecular imprinting: Developments and applications in the analytical chemistry field / L.I. Andersson // J. Chromatogr. B. – 2000. – Vol. 745, № 1. – P. 3–13.
75. Preliminary evaluation of a molecular imprinted polymer for solid-phase extraction of tamoxifen / B.A. Rashid, R.J. Briggs, J.N. Hay et al. // Anal. Commun. – 1997. – Vol. 34. – P. 303–306.
76. Novel enrofloxacin imprinted polymer applied to the solid-phase extraction of fluorinated quinolones from urine and tissue samples / E. Caro, R.M. Marcer, P.A.G. Cormack et al. // Anal. Chim. Acta. – 2006. – Vol. 562, № 2. – P. 145–151.
77. Gholivand M.B. Computer aided-molecular design and synthesis of a high selective molecularly imprinted polymer for solid-phase extraction of furosemide from human plasma / M.B. Gholivand, M. Khodadadian, F. Ahmadi // Anal. Chim. Acta. – 2010. – Vol. 658, № 2. – P. 225–232.
78. Rezaei B. Application of molecularly imprinted polymer for solid phase extraction and preconcentration of hydrochlorothiazide in pharmaceutical and serum sample analysis / B. Rezaei, S. Mallakpour, O. Rahmanian // J. Iran. Chem. Soc. – 2010. – Vol. 7, № 4. – P. 1004–1011.
79. A hydrochlorothiazide-imprinted polymer / W. Chen, F. Liu, K. Li, Y et al. // Anal. Lett. – 2000. – Vol. 33, № 5. – P. 809–818.
80. Andersson L.I. A highly selective solid phase extraction sorbent for pre-concentration of sameridine made by molecular imprinting / L.I. Andersson, A. Paprica, T. Arvidsson // Chromatographia. – 1997. – Vol. 46, № 1–2. – P. 57–62.
81. Virtual imprinting as a tool to design efficient MIPs for photosynthesis-inhibiting herbicides / F. Breton, R. Rouillon, E. V. Piletska et al. // Biosens. Bioelectron. – 2006. – Vol. 22, № 9–10. – P. 1948–1954.
82. Custom synthesis of polymeric adsorbent for extraction of furosemide and bumetanide from human urine / I. Tsyrulneva, O. Zaporozhets, E. Piletska et al. // J. Chin. Adv. Mat. Soc. – 2013.– Vol. 1, № 4. – P. 245–256.
83. Molecular modelling and synthesis of polymer for the extraction of amiloride and triamterene from human urine / I. Tsyrulneva, O. Zaporozhets, E. Piletska et al. // Anal. Meth. – 2014. – Vol. 6. – p. 3429–3435.
Завантаження
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2014 Ю. Цирульнева, інж., О. Запорожець, д-р хім. наук
Ця робота ліцензується відповідно до ліцензії Creative Commons Attribution 4.0 International License.
